Exane BNP Paribas Upgrades MaxLinear to Neutral, Announces $30 Price Target
Portfolio Pulse from richadhand@benzinga.com
Exane BNP Paribas analyst Karl Ackerman has upgraded MaxLinear (NASDAQ:MXL) from Underperform to Neutral and announced a $30 price target.
May 19, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MaxLinear (NASDAQ:MXL) has been upgraded from Underperform to Neutral by Exane BNP Paribas analyst Karl Ackerman, with a $30 price target.
The upgrade from Underperform to Neutral by Exane BNP Paribas analyst Karl Ackerman indicates a more positive outlook on MaxLinear's stock. The announcement of a $30 price target suggests potential upside for the stock, which could lead to a short-term increase in its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100